Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy

Diabetic Medicine

Volumn 16, Issue 5, 1999, Pages 388-394

  Rossing, P ^a   Nielsen, F S ^a   Parving, H H ^a   Christensen, Per Kund ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

Arterial blood pressure; Diabetic nephropathy; Glomerular filtration rate; Type 2 diabetes mellitus

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; ALBUMINURIA; BLOOD PRESSURE; CHOLESTEROL; CHROMIUM RADIOISOTOPES; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; EDETIC ACID; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0032726437     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00063.x     Document Type: Article

References (41)

1. 1 Parving H-H, Østerby R, Anderson PW, Hsueh WA. Diabetic nephropathy. In: Brenner BM, ed. The Kidney, 5th edn. Philadelphia: Saunders; 1996; 1864-1892.
2. 2 Eggers PW. Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med 1988; 318: 223-229.
3. 3 Rettig B, Teutsch SM. The incidence of end-stage renal disease in Type I and Type II diabetes mellitus. Diab Nephropathy 1984; 3: 26-27.
4. 4 Grenfell A, Bewick M, Parsons V, Snowden S, Taube D, Watkins PJ. Non-insulin-dependent diabetes and renal replacement therapy. Diabetic Med 1988; 5: 172-176.
5. 5 Ritz E, Stefanski A. Diabetic nephropathy in type II diabetes. Am J Kidney Dis 1996; 27: 167-194.
6. 6 Mogensen CE. Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment. Scand J Clin Lab Invest 1976; 36: 383-388.
7. 7 Parving H-H, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR. A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 1981; 20: 457-461.
8. 8 Viberti GC, Bilous RW, Mackintosh D, Keen H. Monitoring glomerular function in diabetic nephropathy. Am J Med 1983; 74: 256-264.
9. 9 Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. N Engl J Med 1996; 335: 1636-1642.
10. 10 Levey AS, Gassman J, Hall PM, Walker WG. Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. J Am Soc Nephrol 1991; 1: 1087-1094.
11. 11 Parving H-H, Gall M-A, Skøtt P, Jørgensen HE, Løkkegaard H, Jørgensen F et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992; 41: 758-762.
12. 12 World Health Organization. Diabetes Mellitus, Report of a WHO Study Group, 727th edn. Geneva: WHO, 1985: 7-113.
13. 13 Bröchner-Mortensen J, Rödbro P. Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 1976; 36: 35-45.
14. 14 Bröchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271-274.
15. 15 Ullmann R, Bonitz K. Vollmechanisierte kinetische Messung von Kreatinin. Med Labor Bd 1976; 29: 137-145.
16. 16 Christensen C, Ørskov C. Rapid screening PEG radioimmunoassay for quantification of pathological microalbuminuria. Diab Nephropathy 1984; 3: 92-94.
17. 17 Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985; 45: 539-544.
18. 18 Tarnow L, Rossing P, Gall M-A, Nielsen FS, Parving H-H. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care 1994; 17: 1247-1251.
19. 19 SEHP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. J Am Med Assoc 1991; 265: 3255-3264.
20. 20 Tuomilehto J, Rastenyte D, Thisj L, Staessen J. Reduction of mortality and cardiovascular events in older diabetic patients with isolated systolic hypertension in Europe treated with nitrendipine-based antihypertensive therapy (Syst-Eur Trial). [Abstract] Diabetes 1998; 47 (Suppl. 1): A54.
21. 21 Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension). Lancet 1991; 338: 1281-1285.
22. 22 MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405-412.
23. 23 Curb JD, Pressel SL, Cutler JA, Savage PJ, Appelgate WB, Black H et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. J Am Med Assoc 1996; 276: 1886-1892.
24. 24 UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. Br Med J 1998; 317: 703-713.
25. 25 Hommel E, Jensen B, Parving H-H. Long term effect of captopril on kidney function in normotensive insulin dependent diabetic patients (IDDM) with diabetic nephropathy [Abstract]. J Am Soc Nephrol 1995; 6: 450.
26. 26 Schmidt K, Pesce CM, Liu QZ, Nelson RG, Bennett PH, Karnitschnig H et al. Large glomerular size in Pima Indians: lack of change with diabetic nephropathy. J Am Soc Nephrol 1992; 3: 229-235.
27. 27 Bilous RW, Mauer SM, Sutherland DER, Steffes MW. Mean glomerular volume and rate of development of diabetic nephropathy. Diabetes 1989; 38: 1142-1147.
28. 28 Miller PL, Scholey JW, Rennke HG, Meyer TW. Glomerular hypertrophy aggravates epithelial cell injury in nephrotic rats. J Clin Invest 1990; 85: 1119-1126.
29. 29 Østerby R, Gall M-A, Schmitz A, Nielsen FS, Nyberg G, Parving H-H. Glomerular structure and function in proteinuric Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993; 36: 1064-1070.
30. 30 Rossing P, Hommel E, Smidt UM, Parving H-H. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 1993; 42: 715-719.
31. 31 Parving H-H, Smidt UM, Hommel E, Mathiesen ER, Rossing P, Nielsen FS et al. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy. Am J Kidney Dis 1993; 22: 188-195.
32. 32 Parving H-H, Rossing P, Hommel E, Smidt UM. Angiotensin converting enzyme inhibition in diabetic nephropathy: ten years experience. Am J Kidney Dis 1995; 26: 99-107.
33. 33 Björck S, Mulec H, Johnsen SA, Nordén G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy. Br Med J 1992; 304: 339-343.
34. 34 Breyer JA, Bain P, Evans JK, Nahman NS, Lewis E, Cooper ME et al. Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int 1996; 50: 1651-1658.
35. 35 Yokoyama H, Tomonaga O, Hirayama M, Ishii A, Takeda M, Babazono T et al. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia 1997; 40: 405-411.
36. 36 Bakris GL, Copley JB, Vicknair N, Sadler R, Leugans S. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int 1996; 50: 1641-1650.
37. 37 Bakris GL, Mangrum A, Copley JB, Vicknair N, Sadler R. Effect of calcium channel or β-blockade on the progression of diabetic nephropathy in African Americans. Hypertension 1997; 29: 744-750.
38. 38 Ravid M, Lang R, Rachmani R, Lishner M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. Arch Intern Med 1996; 156: 286-289.
39. 39 Ravid M, Savin H, Lang R, Jutrin I, Ludvinovsky S, Lishner M. Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus. A 14-year follow-up report on 195 patients. Arch Intern Med 1992; 152: 1225-1229.
40. 40 Nyberg G, Blohmé G, Nordén G. Impact of metabolic control in progression of clinical diabetic nephropathy. Diabetologia 1987; 30: 82-86.
41. 41 Alaveras A, Thomas SM, Sagriotis A, Viberti GC. Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. Nephrol Dial Transplant 1997; 12: 71-74.